Skip to content
healthcare.dev

Naproxen Sodium

NDC 62207-762, Naproxen Sodium, tablet, film coated, from Granules India Ltd.

Product NDC
62207-762
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-762 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
62207-762-426220707624250 TABLET, FILM COATED in 1 BOTTLE (62207-762-42)
62207-762-4362207076243100 TABLET, FILM COATED in 1 BOTTLE (62207-762-43)
62207-762-4762207076247500 TABLET, FILM COATED in 1 BOTTLE (62207-762-47)
62207-762-49622070762491000 TABLET, FILM COATED in 1 BOTTLE (62207-762-49)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-762 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-762 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-762. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.